I. Dogan Et Al. , "Predictors of osimertinib response at second-line treatment in EGFR mutant non-small cell lung cancer patients with acquired T790M resistance mutation," Molecular Analysis for Precision Oncology Virtual Congress , vol.32, ELECTR NETWORK, 2021
Dogan, I. Et Al. 2021. Predictors of osimertinib response at second-line treatment in EGFR mutant non-small cell lung cancer patients with acquired T790M resistance mutation. Molecular Analysis for Precision Oncology Virtual Congress , (ELECTR NETWORK).
Dogan, I., Gurbuz, M., Paksoy, N., Khanmamadov, N., Vatansever, S., Saip, P., ... Demirkazik, A.(2021). Predictors of osimertinib response at second-line treatment in EGFR mutant non-small cell lung cancer patients with acquired T790M resistance mutation . Molecular Analysis for Precision Oncology Virtual Congress, ELECTR NETWORK
Dogan, I. Et Al. "Predictors of osimertinib response at second-line treatment in EGFR mutant non-small cell lung cancer patients with acquired T790M resistance mutation," Molecular Analysis for Precision Oncology Virtual Congress, ELECTR NETWORK, 2021
Dogan, I. Et Al. "Predictors of osimertinib response at second-line treatment in EGFR mutant non-small cell lung cancer patients with acquired T790M resistance mutation." Molecular Analysis for Precision Oncology Virtual Congress , ELECTR NETWORK, 2021
Dogan, I. Et Al. (2021) . "Predictors of osimertinib response at second-line treatment in EGFR mutant non-small cell lung cancer patients with acquired T790M resistance mutation." Molecular Analysis for Precision Oncology Virtual Congress , ELECTR NETWORK.
@conferencepaper{conferencepaper, author={I. Dogan Et Al. }, title={Predictors of osimertinib response at second-line treatment in EGFR mutant non-small cell lung cancer patients with acquired T790M resistance mutation}, congress name={Molecular Analysis for Precision Oncology Virtual Congress}, city={}, country={ELECTR NETWORK}, year={2021}}